Forus raises $150M Series C at $3B valuation for prescription AI
Forus, which runs AI agents that handle prior authorization and pharmacy routing for prescriptions, raised a $150M Series C led by Bain Capital Ventures at a $3B valuation, about triple its May valuation.
Forus, which runs AI agents that handle prior authorization and pharmacy routing for prescriptions, raised a $150M Series C led by Bain Capital Ventures at a $3B valuation, about triple its May valuation. (HIT Consultant; Fierce Healthcare)
Existing investors including Thrive Capital, General Catalyst, Accel and Redpoint reinvested. Forus says it works with 9 of the top 15 global biopharma companies. The platform is free to doctors and patients. (HIT Consultant; Fierce Healthcare)